Cargando…
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420739/ https://www.ncbi.nlm.nih.gov/pubmed/22937311 http://dx.doi.org/10.1155/2011/692982 |
_version_ | 1782240912694312960 |
---|---|
author | Zaenker, Stephan Schweyer, Stefan Hasenkamp, Justin Truemper, Lorenz Wulf, Gerald |
author_facet | Zaenker, Stephan Schweyer, Stefan Hasenkamp, Justin Truemper, Lorenz Wulf, Gerald |
author_sort | Zaenker, Stephan |
collection | PubMed |
description | Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control. |
format | Online Article Text |
id | pubmed-3420739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34207392012-08-30 Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement Zaenker, Stephan Schweyer, Stefan Hasenkamp, Justin Truemper, Lorenz Wulf, Gerald Case Rep Hematol Case Report Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control. Hindawi Publishing Corporation 2011 2011-09-05 /pmc/articles/PMC3420739/ /pubmed/22937311 http://dx.doi.org/10.1155/2011/692982 Text en Copyright © 2011 Stephan Zaenker et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Zaenker, Stephan Schweyer, Stefan Hasenkamp, Justin Truemper, Lorenz Wulf, Gerald Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title | Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title_full | Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title_fullStr | Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title_full_unstemmed | Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title_short | Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement |
title_sort | granulocytic sarcoma by aml m4eo (inv16) after allogeneic stem cell transplantation without bone marrow involvement |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420739/ https://www.ncbi.nlm.nih.gov/pubmed/22937311 http://dx.doi.org/10.1155/2011/692982 |
work_keys_str_mv | AT zaenkerstephan granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement AT schweyerstefan granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement AT hasenkampjustin granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement AT truemperlorenz granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement AT wulfgerald granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement |